AD/PD 2025 Conference Symposium Agenda
Valiltramiprosate Effects in APOLLOE4 Phase 3 Study in APOE4/4 Homozygotes with Early AD
| Dr. Scheltens [00:00] |
Chair’s Welcome & Program Objectives |
| Dr. Porsteinsson [02:30] |
APOLLOE4 Phase 3 Study Clinical Efficacy, Safety & Baseline Plasma Biomarker Results |
| Dr. Doraiswamy [25:50] |
Volumetric MRI & Microstructural DTI Results |
| Dr. Watson [42:25] |
Perspectives from Clinical Practice in APOE4/4 Patients |
| Dr. Scheltens [50:00] |
Questions and Answers |
For privacy reasons Vimeo needs your permission to be loaded. For more details, please see our Privacy Policy.